The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma
Authors:
- Sarah GwynSGSarah Gwyn
- Andrew W. NuteANAndrew W. Nute
- Eshetu SataESEshetu Sata
- Zerihun TadesseZTZerihun Tadesse
- Ambahun ChernetACAmbahun Chernet
- Mahteme HaileMHMahteme Haile
- Taye ZeruTZTaye Zeru
- Danaya BetheaDBDanaya Bethea
- Christian LaurentCLChristian Laurent
- E. Kelly CallahanECE. Kelly Callahan
- Scott D. NashSNScott D. Nash
- Diana L. MartinDMDiana L. Martin
Open Access
- 3 November 2021
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 105 (5) , 1362-1367
Abstract
: Programs to eliminate trachoma as a public health problem use prevalence of the clinical sign trachomatous inflammation—follicular (TF) in 1- to 9-year-olds in endemic districts to make decisions to begin or end mass drug administration with azithromycin. Trachomatous inflammation—follicular is used as a proxy for transmission of ocular Chlamydia trachomatis infection. Long-term monitoring of previously endemic districts for recrudescence of ocular C. trachomatis infection would benefit from a simple blood test that could be integrated with other public health programs. In this study, we evaluated multiple tests to measure antibodies against the C. trachomatis antigen Pgp3—a multiplex bead assay (MBA), an ELISA, and two versions of a lateral flow assay (LFA)—in four districts of the Amhara region of Ethiopia with varying levels of TF. Seroprevalence and seroconversion rate (SCR) results were proportional to TF prevalence by district for most tests, with the notable exception of the LFA using colloidal gold as the developing reagent. Changing the test developing reagent to black latex improved agreement between serological measures and TF prevalence and in inter-rater agreement. Seroconversion rate estimates using data derived from the LFA-gold assay were inconsistent with the shape of the age-seroprevalence curve, which did not increase in older ages. These data revealed potential complications with using SCR that will need further evaluation. Data from MBA, ELISA, and LFA with the black test line showed good agreement with each other and proportionality to TF estimates, providing further data that serology has potential utility for trachoma surveillance.Keywords
This publication has 22 references indexed in Scilit:
- Lateral flow-based antibody testing for Chlamydia trachomatisJournal of Immunological Methods, 2016
- Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasisParasites & Vectors, 2016
- Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort StudyPLOS ONE, 2016
- Serological Measures of Trachoma Transmission IntensityScientific Reports, 2015
- Serology for Trachoma Surveillance after Cessation of Mass Drug AdministrationPLOS Neglected Tropical Diseases, 2015
- CT694 and pgp3 as Serological Tools for Monitoring Trachoma ProgramsPLOS Neglected Tropical Diseases, 2012
- Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion RatesPLOS ONE, 2009
- The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and ControlPLOS Neglected Tropical Diseases, 2009
- Serology: a robust indicator of malaria transmission intensity?Trends in Parasitology, 2007
- Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposureProceedings of the National Academy of Sciences, 2005